Clinical trial

Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases

NCT06842316

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-04-10

PhaseN/A

Study timeline

Study start (actual)2025-04-10Date precision: day

Registry last updated2025-12-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Inflammatory Disorder of Immune Systemunresolved

Spondylitis, Ankylosingunresolved

Arthritis, Rheumatoidunresolved

Arthritis, Psoriaticunresolved

Inflammatory Bowel Diseasesunresolved

Sjogren's Syndromeunresolved

Lupus Erythematosus, Systemicunresolved

Interventions

1 blood sample, 40 mL (collection during a blood test, part of the standard of care for this disease)OTHER

Sponsors & collaborators

Centre Hospitalier Régional d'Orléanslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06842316 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.